• Please log in or register to access this feature.
You have full text access to this OnlineOpen article

Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease

  1. U. Mahadevan1,
  2. S. Kane2,
  3. W. J. Sandborn3,
  4. R. D. Cohen2,
  5. K. Hanson3,
  6. J. P. Terdiman1,
  7. D. G. Binion4

Article first published online: 17 MAR 2005

DOI: 10.1111/j.1365-2036.2005.02405.x

Issue

Alimentary Pharmacology & Therapeutics

Alimentary Pharmacology & Therapeutics

Volume 21, Issue 6, pages 733–738, March 2005

Additional Information

How to Cite

Mahadevan, U., Kane, S., Sandborn, W. J., Cohen, R. D., Hanson, K., Terdiman, J. P. and Binion, D. G. (2005), Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease. Alimentary Pharmacology & Therapeutics, 21: 733–738. doi: 10.1111/j.1365-2036.2005.02405.x

Author Information

  1. 1

    Division of Gastroenterology, Department of Medicine, University of California San Francisco, San Francisco, CA, USA

  2. 2

    Section of Gastroenterology, University of Chicago, Chicago, IL, USA

  3. 3

    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA

  4. 4

    Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, WI, USA

*Dr U. Mahadevan, UCSF Center for Colitis and Crohn's Disease, 2330 Post Street No. 610, San Francisco, CA 94115, USA. E-mail: umamah@itsa.ucsf.edu

Publication History

  1. Issue published online: 17 MAR 2005
  2. Article first published online: 17 MAR 2005
  3. Accepted for publication 17 January 2005

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (63K)

References

  • 1
    Andres PG, Friedman LS. Epidemiology and the natural course of inflammatory bowel disease. Gastroenterol Clin North Am 1999; 28: 255–81, vii.
  • 2
    Targan SR, Hanauer SB, van Deventer SJ, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 1997; 337: 1029–35.
  • 3
    Hanauer SB, Feagan BG, Lichtenstein GR, et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 2002; 359: 1541–9.
  • 4
    Hanauer SB, Sandborn W. Management of Crohn's disease in adults. Am J Gastroenterol 2001; 96: 635–43.
    Direct Link:
  • 5
    Fenton TR. A new growth chart for preterm babies: Babson and Benda's chart updated with recent data and a new format. BMC Pediatr 2003; 3: 13.
  • 6
    Simister NE. Placental transport of immunoglobulin G. Vaccine 2003; 21: 3365–9.
  • 7
    Sands BE, Anderson FH, Bernstein CN, et al. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med 2004; 350: 876–85.
  • 8
    Baert F, Noman M, Vermeire S, et al. Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease. N Engl J Med 2003; 348: 601–8.
  • 9
    Srinivasan R. Infliximab treatment and pregnancy outcome in active Crohn's disease. Am J Gastroenterol 2001; 96: 2274–5.
    Direct Link:
  • 10
    James RLPL. Successful treatment of pregnancy-triggered Crohn's disease complicated by severe recurrent life-threatening gastrointestinal bleeding. Am J Gastroenterol 2001; 96: S295.
  • 11
    Bank LHB. Unexpected dramatic clinical response of psoriasis lesions and unexpected pregnancy in an infertile patient in response to treatment with anti-tumor necrosis factor monoclonal antibody for Crohn's disease. Am J Gastroenterol 2002; 97: S260.
  • 12
    Burt MJ, Frizelle FA, Barbezat GO. Pregnancy and exposure to infliximab (anti-tumor necrosis factor-alpha monoclonal antibody). J Gastroenterol Hepatol 2003; 18: 465–6.
    Direct Link:
  • 13
    Dechant C, Antoni C, Wendler J, et al. One Year Outcome of Patients with Severe Psoriatic Arthritis Treated with Infliximab. Arthritis Rheum 2000; 43: 214.
  • 14
    Chakravarty EF, Sanchez-Yamamoto D, Bush TM. The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: a survey of practice patterns and pregnancy outcomes. J Rheumatol 2003; 30: 241–6.
  • 15
    Kinder AJ, Edwards J, Samanta A, Nichol F. Pregnancy in a rheumatoid arthritis patient on infliximab and methotrexate. Rheumatology (Oxford) 2004; 43: 1195–6.
  • 16
    Lichtenstein G, Cohen RD, Feagan BG, et al. Safety of Infliximab in Crohn's disease: data from the 5000 – patient TREAT registry. Gastroenterology 2004; 126: A54.
  • 17
    Katz JA, Antoni C, Keenan GF, Smith DE, Jacobs SJ, Lichtenstein GR. Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis. Am J Gastroenterol 2004; 99: 2385–92.
    Direct Link:
  • 18
    Peltier M, James D, Ford J, et al. Infliximab levels in breast-milk of a nursing Crohn's patient. Am Coll Gastroenterol 2001; 96: P258.
View Full Article (HTML) Get PDF (63K)